Reply to S. Iwase et al

J Clin Oncol. 2016 Feb 1;34(4):392. doi: 10.1200/JCO.2015.64.8402. Epub 2015 Nov 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Antioxidants / administration & dosage*
  • Deoxycytidine / analogs & derivatives*
  • Female
  • Fluorouracil / analogs & derivatives*
  • Hand-Foot Syndrome / prevention & control*
  • Humans
  • Keratolytic Agents / administration & dosage*
  • Male
  • Primary Prevention / methods*
  • Quality of Life*
  • Urea / administration & dosage*

Substances

  • Antimetabolites, Antineoplastic
  • Antioxidants
  • Keratolytic Agents
  • Deoxycytidine
  • Urea
  • Fluorouracil